SKF-10047, a prototype Sigma-1 receptor agonist, augmented the membrane trafficking and uptake activity of the serotonin transporter and its C-terminus-deleted mutant via a Sigma-1 receptor-independent mechanism
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 139 (1) , 29-36
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Sports and Culture
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japanese Smoking Research Association
This publication has 33 references indexed in Scilit:
- Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disordersExpert Opinion on Therapeutic Targets, 2011
- The Cystic Fibrosis Transmembrane Conductance Regulator's Expanding SNARE InteractomeTraffic, 2011
- Syntaxin 3 is necessary for cAMP- and cGMP-regulated exocytosis of CFTR: implications for enterotoxigenic diarrheaAmerican Journal of Physiology-Cell Physiology, 2010
- Mutations in the Carboxyl-terminal SEC24 Binding Motif of the Serotonin Transporter Impair Folding of the TransporterJournal of Biological Chemistry, 2010
- Enhanced activity of human serotonin transporter variants associated with autismPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT)Neurochemistry International, 2005
- Adenosine Receptor, Protein Kinase G, and p38 Mitogen-Activated Protein Kinase-Dependent Up-Regulation of Serotonin Transporters Involves Both Transporter Trafficking and ActivationMolecular Pharmacology, 2004
- Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotypeMolecular Psychiatry, 2003
- Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT GeneScience, 2003
- Cloning and expression of a functional serotonin transporter from rat brainNature, 1991